keyword
https://read.qxmd.com/read/38613648/the-impact-of-prevotella-on-neurobiology-in-aging-deciphering-dendritic-cell-activity-and-inflammatory-dynamics
#1
REVIEW
Ahmed Hs
Prevotella species, notably Prevotella copri, significantly populate the human gut. In particular, P. copri is prevalent among non-Western populations with diets high in fiber. These species show complex relationships with diverse health aspects, associating with beneficial outcomes, including reduced visceral fat and improved glucose tolerance. Studies implicate various Prevotella species in specific diseases. Prevotella nigrescens and Porphyromonas gingivalis were linked to periodontal disease, promoting immune responses and influencing T helper type 17 (Th17) cells...
April 13, 2024: Molecular Neurobiology
https://read.qxmd.com/read/38607732/cell-free-dna-as-peripheral-biomarker-of-alzheimer-s-disease
#2
REVIEW
Sachi Khemka, Ujala Sehar, Pulak R Manna, Sudhir Kshirsagar, P Hemachandra Reddy
Alzheimer's disease (AD) and Alzheimer's disease-related disorders (ADRD) are progressive neurodegenerative diseases without cure. Alzheimer's disease occurs in 2 forms, early-onset familial AD and late-onset sporadic AD. Early-onset AD is a rare (~1%), autosomal dominant, caused by mutations in presenilin-1, presenilin-2, and amyloid precursor protein genes and the other is a late-onset, prevalent and is evolved due to age-associated complex interactions between environmental and genetic factors, in addition to apolipoprotein E4 polymorphism...
April 4, 2024: Aging and Disease
https://read.qxmd.com/read/38592348/a-non-coronary-peripheral-arterial-atherosclerotic-disease-carotid-renal-lower-limb-in-elderly-patients-a-review-part-ii-pharmacological-approach-for-management-of-elderly-patients-with-peripheral-atherosclerotic-lesions-outside-coronary-territory
#3
REVIEW
Marcin Piechocki, Tadeusz Przewłocki, Piotr Pieniążek, Mariusz Trystuła, Jakub Podolec, Anna Kabłak-Ziembicka
Aging is a key risk factor for atherosclerosis progression that is associated with increased incidence of ischemic events in supplied organs, including stroke, coronary events, limb ischemia, or renal failure. Cardiovascular disease is the leading cause of death and major disability in adults ≥ 75 years of age. Atherosclerotic occlusive disease affects everyday activity, quality of life, and it is associated with reduced life expectancy. As most multicenter randomized trials exclude elderly and very elderly patients, particularly those with severe comorbidities, physical or cognitive dysfunctions, frailty, or residence in a nursing home, there is insufficient data on the management of older patients presenting with atherosclerotic lesions outside coronary territory...
March 5, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38591204/functional-investigation-and-two-sample-mendelian-randomization-study-of-inguinal-hernia-hub-genes-obtained-by-bioinformatics-analysis
#4
JOURNAL ARTICLE
De Kun Lu, Zheng Chang Guo, Jia Jia Zhang, Xin Yu, Zong Yao Zhang
BACKGROUND: Inguinal hernia in adults is a common and frequent disease in surgery, prone to occur in the elderly or in those with a weak abdominal wall. Despite its prevalence, Molecular mechanisms underlying inguinal hernia formation are unclear. OBJECTIVE: This study aims to identify potential gene markers for inguinal hernia and available drugs. METHODS: Pubmed2Ensembl text mining was used to identify genes related to "inguinal hernia" keywords...
April 5, 2024: Current Computer-aided Drug Design
https://read.qxmd.com/read/38574838/n6022-attenuates-cerebral-ischemia-reperfusion-injury-induced-microglia-ferroptosis-by-promoting-nrf2-nuclear-translocation-and-inhibiting-the-gsnor-gstp1-axis
#5
JOURNAL ARTICLE
Wan-Li Duan, Ya-Ping Ma, Xue-Jie Wang, Chang-Sheng Ma, Bo Han, Zhi-Mei Sheng, Hao Dong, Li-Ying Zhang, P Andy Li, Bao-Gang Zhang, Mao-Tao He
Stroke poses a significant risk of mortality, particularly among the elderly population. The pathophysiological process of ischemic stroke is complex, and it is crucial to elucidate its molecular mechanisms and explore potential protective drugs. Ferroptosis, a newly recognized form of programmed cell death distinct from necrosis, apoptosis, and autophagy, is closely associated with the pathophysiology of ischemic stroke. N6022, a selective inhibitor of S-nitrosoglutathione reductase (GSNOR), is a "first-in-class" drug for asthma with potential therapeutic applications...
April 2, 2024: European Journal of Pharmacology
https://read.qxmd.com/read/38571339/predictors-of-potential-clinically-harmful-drug-drug-interactions-at-the-medical-wards-in-the-university-of-benin-teaching-hospital-benin-city
#6
JOURNAL ARTICLE
Oseremen Godstime Oriaifo, Abimbola Olubukunola Opadeyi, Tracy Oseremen Oriaifo, Ambrose Ohumagho Isah
Drug-drug interactions are preventable causes of adverse events. Different factors have been recognized as important predictors of drug-drug interactions but few studies have addressed these predictors in patients admitted into medical wards of a tertiary hospital in Nigeria hence this study. This was a retrospective study conducted using case records of patients admitted into the medical wards between January 1 and December 31, 2020. Patients were selected using a systematic random sampling method. Socio-demographic details including age, gender, number of comorbidities, and number of medications prescribed and diagnosis were collected on days 1, 3, and at discharge...
April 2024: Clinical and Translational Science
https://read.qxmd.com/read/38558319/brivaracetam-use-in-clinical-practice-a-delphi-consensus-on-its-role-as-first-add-on-therapy-in-focal-epilepsy-and-beyond
#7
JOURNAL ARTICLE
Simona Lattanzi, Valentina Chiesa, Giancarlo Di Gennaro, Edoardo Ferlazzo, Angelo Labate, Angela La Neve, Stefano Meletti, Carlo Di Bonaventura
BACKGROUND: Antiseizure medications remain the cornerstone of treatment for epilepsy, although a proportion of individuals with the condition will continue to experience seizures despite appropriate therapy. Treatment choices for epilepsy are based on variables related to both the individual patient and the available medications. Brivaracetam is a third-generation agent antiseizure medication. METHODS: We carried out a Delphi consensus exercise to define the role of brivaracetam in clinical practice and to provide guidance about its use as first add-on ASM and in selected clinical scenarios...
April 1, 2024: Neurological Sciences
https://read.qxmd.com/read/38550918/updates-of-the-role-of-b-cells-in-ischemic-stroke
#8
REVIEW
Silin Wu, Sidra Tabassum, Cole T Payne, Heng Hu, Aaron M Gusdon, Huimahn A Choi, Xuefang S Ren
Ischemic stroke is a major disease causing death and disability in the elderly and is one of the major diseases that seriously threaten human health and cause a great economic burden. In the early stage of ischemic stroke, neuronal structure is destroyed, resulting in death or damage, and the release of a variety of damage-associated pattern molecules induces an increase in neuroglial activation, peripheral immune response, and secretion of inflammatory mediators, which further exacerbates the damage to the blood-brain barrier, exacerbates cerebral edema, and microcirculatory impairment, triggering secondary brain injuries...
2024: Frontiers in Cellular Neuroscience
https://read.qxmd.com/read/38529187/pharmacological-treatments-and-medication-related-problems-in-nursing-homes-in-catalonia-a-multidisciplinary-approach
#9
JOURNAL ARTICLE
Emilie Anderssen-Nordahl, Margarita Sánchez-Arcilla Rosanas, Montserrat Bosch Ferrer, Mònica Sabaté Gallego, Eladio Fernández-Liz, Antonio San-José, Maria Estrella Barceló-Colomer
Background: Aging correlates with increased frailty, multi-morbidity, and chronic diseases. Furthermore, treating the aged often entails polypharmacy to achieve optimal disease management, augmenting medication-related problems (MRPs). Few guidelines and tools address the problem of polypharmacy and MRPs, mainly within the institutionalized elderly population. Routine pharmacological review is needed among institutionalized patients. This pharmacological review may improve with a multidisciplinary approach of a collaboration of multiple health professionals...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38509766/frailty-in-clinical-drug-trials-frailty-assessments-subgroup-analyses-and-outcomes
#10
REVIEW
Tu N Nguyen, Fahed Ahmad, Richard I Lindley
With population ageing, drug trials are increasingly turning their attention to including older, frailer people. This review aimed to provide an overview of how frailty was assessed in published studies related to clinical pharmacological trials, and on the interaction of frailty on the efficacy of the treatments. We searched MEDLINE, EMBASE and Cochrane for clinical drug trials in older people. A total of 4031 abstracts were screened and 17 relevant studies were included in this review. We summarized the findings of these 17 trials into five main clinical areas: cardiovascular (eight studies), cognition (one study), vaccination (two studies), cancer (four studies) and other (two studies)...
March 21, 2024: British Journal of Clinical Pharmacology
https://read.qxmd.com/read/38497076/deciphering-aging-associated-molecular-mechanisms-in-bone-marrow-derived-hematopoietic-stem-cells-in-the-elderly-using-ngs-data
#11
JOURNAL ARTICLE
Hind A Alkhatabi
Aging is a complex process that is not yet fully understood. Despite advancements in research, a deeper understanding of the underlying biological mechanisms is necessary to develop interventions that promote healthy longevity. The aim of this study was to elucidate the complex mechanisms associated with healthy aging and longevity in healthy elderly individuals. The RNA sequencing (RNA-seq) data used in this study was obtained from the Gene Expression Omnibus (GEO) database (accession number GSE104406), which was collected from Fluorescent Activated Cell Sorting (FACS) of human bone marrow derived human hematopoietic stem cells (BM-HSCs) (Lineage-, CD34+, CD38-) young (18-30 years old) and aged (65-75 years old) donors who had no known hematological malignancy, with 10 biological replicates per group...
2024: Bioinformation
https://read.qxmd.com/read/38465112/retrospective-analysis-of-potential-adverse-drug-interactions-in-the-drugs-prescribed-to-the-elderly-at-a-tertiary-health-care-center-in-raipur-chhattisgarh-central-india
#12
JOURNAL ARTICLE
Yazhini Rajendran, Yogendra Keche, Nitin R Gaikwad, Suryaprakash Dhaneria
Background The elderly population differs from adults in having various physiological changes and multiple diseases, which demand the use of multiple medications. The practice of polypharmacy in the elderly leads to numerous harmful effects like adverse drug reactions, adverse drug-drug interactions (DDIs), poor compliance, etc. Methodology This study collected 295 case files of elderly patients retrospectively in the Departments of General Medicine, Cardiology and Nephrology after obtaining Institute Ethics Committee approval to look for the potential adverse DDIs with their severity according to the clinical significance...
February 2024: Curēus
https://read.qxmd.com/read/38434703/evaluation-of-medication-safety-assessment-tools-for-pharmacist-led-medication-reviews-the-eastern-european-pilot-project
#13
JOURNAL ARTICLE
Anita Tuula, Piotr Merks, Magdalena Waszyk-Nowaczyk, Mariola Drozd, Galina Petrova, Reka Viola, Veera Bobrova, Michael Scott, Marje Oona, Daisy Volmer
Background: Pharmacist-led medication reviews (MR) are one of the key methods to support medication safety in polypharmacy patients. The aims of this study were to pilot MRs in Eastern European community pharmacies, describe medication use in polypharmacy patients, and evaluate the usability of medication safety assessment tools. Methods: The MR pilot was undertaken in Estonia, Latvia, Poland, Hungary, Romania, and Bulgaria. Patients who used at least five medicines were directed to the service by their GPs...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38417790/facing-the-facts-of-altered-plasma-protein-binding-do-current-models-correctly-predict-changes-in-fraction-unbound-in-special-populations
#14
JOURNAL ARTICLE
Jokha Al-Qassabi, Shawn Pei Feng Tan, Patcharapan Phonboon, Aleksandra Galetin, Amin Rostami-Hodjegan, Daniel Scotcher
Accounting for variability in plasma protein binding of drugs is an essential input to physiologically-based pharmacokinetic (PBPK) models of special populations. Prediction of fraction unbound in plasma (fu) in such populations typically considers changes in plasma protein concentration while assuming that the binding affinity remains unchanged. A good correlation between predicted vs observed fu data reported for various drugs in a given special population is often used as a justification for such predictive methods...
February 26, 2024: Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38399331/chitosan-and-anionic-solubility-enhancer-sulfobutylether-%C3%AE-cyclodextrin-based-nanoparticles-as-dexamethasone-ophthalmic-delivery-system-for-anti-inflammatory-therapy
#15
JOURNAL ARTICLE
Giuseppe Francesco Racaniello, Gennaro Balenzano, Ilaria Arduino, Rosa Maria Iacobazzi, Antonio Lopalco, Angela Assunta Lopedota, Hakon Hrafn Sigurdsson, Nunzio Denora
Cataract surgery interventions are constantly increasing, particularly among adult and elderly patients. This type of surgery can lead to inflammatory states of the ocular anterior segment (AS), usually healed via postoperative treatment with dexamethasone (DEX)-containing eye drops. The application of eye drops is challenging due to the high number of daily administrations. In this study, mucoadhesive nanoparticles (NPs) were formulated to improve the residence time of DEX on the corneal mucosa, enhancing the drug's solubility and bioavailability...
February 16, 2024: Pharmaceutics
https://read.qxmd.com/read/38392779/management-of-polypharmacy-and-potential-drug-drug-interactions-in-patients-with-pulmonary-aspergillosis-a-2-year-study-of-a-multidisciplinary-outpatient-clinic
#16
JOURNAL ARTICLE
Dario Cattaneo, Alessandro Torre, Marco Schiuma, Aurora Civati, Giacomo Casalini, Andrea Gori, Spinello Antinori, Cristina Gervasoni
Pulmonary aspergillosis mainly affects elderly patients, patients with pulmonary complications, patients with hematological malignancies, organ transplant recipients, or critically ill patients. Co-morbidities may result in a high rate of polypharmacy and a high risk of potential drug-drug interaction (pDDI)-related antifungal azoles, which are perpetrators of several pharmacokinetic- and pharmacodynamic-driven pDDIs. Here, we report the results of the first 2-year study of an outpatient clinic focusing on the management of therapies in patients with pulmonary aspergillosis...
January 26, 2024: Journal of Fungi (Basel, Switzerland)
https://read.qxmd.com/read/38389602/analysis-of-drugs-prescribed-to-elderly-patients-in-a-tertiary-health-care-center-in-raipur-central-india-an-observational-study
#17
JOURNAL ARTICLE
Yogendra Keche, Nitin R Gaikwad, Preetam N Wasnik, Keshao Nagpure, Md Sabah Siddiqui, Apoorva Joshi, Suryaprakash Dhaneria, Gevesh Dewangan, Jhasaketan Meher, Pranita Das
Background Most elderly patients suffer from multiple diseases and are on multiple drugs for treatment. Polypharmacy in the elderly, physiological changes with old age, changes in the pharmacokinetics and pharmacodynamic effects of many drugs, and newer drug prescription trends for diseases like diabetes and cardiovascular disease make drug prescribing in the elderly more difficult. There are many chances of drug-drug interactions with easily available over-the-counter (OTC) medications. To prevent the irrational use of drugs in the elderly, there is a need for prescription analysis studies...
January 2024: Curēus
https://read.qxmd.com/read/38389505/impacts-of-febuxostat-on-cerebral-and-cardiovascular-events-in-elderly-patients-with-hyperuricemia-post-hoc-analysis-of-a-randomized-controlled-trial
#18
JOURNAL ARTICLE
Masahiro Sugawara, Sunao Kojima, Ichiro Hisatome, Kunihiko Matsui, Kazuaki Uchiyama, Naoto Yokota, Eiichi Tokutake, Yutaka Wakasa, Shinya Hiramitsu, Masako Waki, Hideaki Jinnouchi, Hirokazu Kakuda, Takahiro Hayashi, Naoki Kawai, Hisao Mori, Kenichi Tsujita, Yusuke Ohya, Kazuo Kimura, Yoshihiko Saito, Hisao Ogawa
A recent meta-analysis found no benefit of uric acid-lowering therapy including febuxostat on death, cardiovascular events, or renal impairment. However, there may be populations that benefit from febuxostat in reducing mortality and cerebral and cardiovascular events. The aim of the present study was to examine the clinical benefit of febuxostat in elderly patients stratified by age using Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy (FREED) data. FREED was a randomized study involving patients aged 65 years or older with hyperuricemia and risk factors for cerebral, cardiovascular, or renal diseases...
February 23, 2024: Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/38385117/recommendations-for-cyclin%C3%A2-dependent-kinase-4-6-inhibitor-treatments-in-the-context-of-co%C3%A2-morbidity-and-drug-interactions-review
#19
REVIEW
Mehmet Teomete, Devrim Cabuk, Taner Korkmaz, Selcuk Seber, Ozge Fulya Ozturk, Birkan Aver, Atila Karaalp, Gul Basaran
Breast cancer is most frequently diagnosed among women aged 65-74 years and the prevalence of comorbidities in elderly patients with breast cancer is 32.2%. In addition, polypharmacy is quite common in these patients. Understanding the interaction between breast cancer treatment modalities and comorbidities is important, particularly in elderly patients, as comorbidities affect the choice of appropriate treatment and are independent risk factors for survival. A total of three oral cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i), palbociclib, ribociclib and abemaciclib, notably prolonged progression-free survival when combined with endocrine therapy (ET), compared with ET alone in patients with advanced breast cancer (ABC)...
April 2024: Oncology Letters
https://read.qxmd.com/read/38338436/neuroprotection-of-truncated-peptide-iiave-from-isochrysis-zhanjiangensis-quantum-chemical-molecular-docking-and-bioactivity-studies
#20
JOURNAL ARTICLE
Qiuqi Liu, Liyuan Lin, Huijuan Li, Zhong-Ji Qian
Parkinson's disease (PD) is a progressive neurodegenerative disorder of the elderly for which there is no cure or disease-modifying therapy. Mitochondrial dysfunction and oxidative stress play a central role in dopaminergic neurodegeneration in PD. Therefore, antioxidants are considered a promising neuroprotective approach. In in vivo activity studies, 6-OHDA-induced oxidative stress in SH-SY5Y cells was established as a model of PD for cellular experiments. IIAVE (Ile-Ile-Ala-Val-Glu) was derived from Isochrysis zhanjiangensis octapeptide (IIAVEAGC), which has a small molecular weight...
February 2, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
keyword
keyword
114763
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.